What Makes an Expert Barrett's Histopathologist?

Area of Science:

• Gastroenterology
• Oncology
• Pathology

Background:

• Barrett's esophagus (BO) progression to esophageal adenocarcinoma involves clonal evolution and competition.
• Current markers for BO progression, like dysplastic epithelial changes, have limitations in sensitivity and specificity.
• Interobserver variability among histopathologists challenges accurate diagnosis and prediction of disease progression.

Purpose of the Study:

• To review the histopathology of Barrett's dysplasia and its role in managing BO.
• To emphasize the importance of histopathologist expertise in diagnosing and managing BO.
• To discuss factors contributing to interobserver variability and potential solutions.

Main Methods:

• Review of histopathology literature on Barrett's dysplasia.
• Evaluation of factors influencing interobserver variability in diagnosing dysplasia.
• Discussion of adjunct tests like p53 immunohistochemistry and standardized reporting.

Main Results:

• Dysplastic changes are a proxy for clonal dynamics but lack sensitivity for non-morphologic clonal expansions.
• Interobserver variability necessitates expert confirmation, highlighting the need for defined expertise criteria.
• Adjunct tests and standardized protocols can improve diagnostic uniformity.

Conclusions:

• Accurate histopathological diagnosis of Barrett's dysplasia is critical for patient management.
• Standardized criteria and expertise are needed to reduce variability and improve risk stratification.
• Collaborative efforts between histopathologists and clinicians are essential for optimal care of BO patients.